These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30115078)

  • 21. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
    Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
    Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
    Kim EJ; Kim SH; Jin X; Jin X; Kim H
    Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
    Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
    Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
    Yang F; Li S; Cheng Y; Li J; Han X
    Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
    Wang X; Huang Z; Wu Q; Prager BC; Mack SC; Yang K; Kim LJY; Gimple RC; Shi Y; Lai S; Xie Q; Miller TE; Hubert CG; Song A; Dong Z; Zhou W; Fang X; Zhu Z; Mahadev V; Bao S; Rich JN
    Cancer Res; 2017 Sep; 77(18):4947-4960. PubMed ID: 28729418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
    Ma S; Zhao X
    Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
    Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
    Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-MYC inhibition impairs hypoxia response in glioblastoma multiforme.
    Mongiardi MP; Savino M; Falchetti ML; Illi B; Bozzo F; Valle C; Helmer-Citterich M; Ferrè F; Nasi S; Levi A
    Oncotarget; 2016 May; 7(22):33257-71. PubMed ID: 27119353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity.
    Sun J; He D; Fu Y; Zhang R; Guo H; Wang Z; Wang Y; Gao T; Wei Y; Guo Y; Pang Q; Liu Q
    J Exp Clin Cancer Res; 2021 Jun; 40(1):187. PubMed ID: 34099027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.
    Tateishi K; Iafrate AJ; Ho Q; Curry WT; Batchelor TT; Flaherty KT; Onozato ML; Lelic N; Sundaram S; Cahill DP; Chi AS; Wakimoto H
    Clin Cancer Res; 2016 Sep; 22(17):4452-65. PubMed ID: 27076630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KPNA2 promotes renal cell carcinoma proliferation and metastasis via NPM.
    Zheng S; Li X; Deng T; Liu R; Bai J; Zuo T; Guo Y; Chen J
    J Cell Mol Med; 2021 Oct; 25(19):9255-9267. PubMed ID: 34469024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
    Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
    Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Karyopherin Alpha 2 Promotes the Inflammatory Response in Rat Pancreatic Acinar Cells Via Facilitating NF-κB Activation.
    Cai Y; Shen Y; Gao L; Chen M; Xiao M; Huang Z; Zhang D
    Dig Dis Sci; 2016 Mar; 61(3):747-57. PubMed ID: 26526450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
    Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
    Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
    Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KPNA2 interacts with P65 to modulate catabolic events in osteoarthritis.
    Tao R; Xu X; Sun C; Wang Y; Wang S; Liu Z; Zhai L; Cheng H; Xiao M; Zhang D
    Exp Mol Pathol; 2015 Oct; 99(2):245-52. PubMed ID: 26209501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.